步长制药：关于以集中竞价交易方式回购股份方案暨取得金融机构回购专项贷款承诺函的公告

Core Viewpoint - The company plans to repurchase shares using its own funds and special loans from financial institutions, with a total repurchase amount ranging from 60 million to 120 million yuan, at a price not exceeding 23.98 yuan per share [1] Group 1: Share Repurchase Details - The repurchase will be conducted through centralized bidding transactions [1] - The purpose of the repurchased shares includes implementing equity incentives, employee stock ownership plans, and converting convertible bonds issued by the company into stocks [1] - The repurchase period is set to be no more than twelve months from the date the board of directors approves the repurchase plan [1] Group 2: Funding Sources - The funding for the repurchase will come from the company's own funds and special loans from financial institutions, with at least 10% of the total repurchase amount coming from the company's own funds [1] - The special loans from financial institutions will not exceed 90% of the total repurchase amount [1] - The company has received a loan commitment letter from China Agricultural Bank, promising a loan amount of 100 million yuan with a term of three years and an annual interest rate of 2% [1]